Literature DB >> 32918090

Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological Agents.

Thomas E Conley1, Chris Probert2, Sreedhar Subramanian1.   

Abstract

Entities:  

Keywords:  Covid-19; Inflammatory bowel disease; biologics

Mesh：

Substances：

Year:  2020        PMID： 32918090      PMCID： PMC7543299          DOI： 10.1093/ecco-jcc/jjaa187

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  2 in total

Review 1.  Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.

Authors:  Long Chen; Kai Hu; Cheng Cheng; Quanman Hu; Liang Zhang; Tongyan An; Yongjun Guo; Shuaiyin Chen; Guangcai Duan
Journal:  Int J Colorectal Dis       Date:  2022-10-22       Impact factor: 2.796

2.  Impact of biologics and small molecules for inflammatory bowel disease on COVID-19-related hospitalization and mortality: A systematic review and meta-analysis.

Authors:  Fatema Alrashed; Hajer Alasfour; Mohammad Shehab
Journal:  JGH Open       Date:  2022-03-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.